1. Pink Sheet
  2. >>Market Access

Private Sector Will Be Key Source Of Data To Inform Value-Based Coverage Decisions – Former Merck Exec Spatz

 
• By Gregory Twachtman

New data, not just an analysis of existing data, is needed to achieve the goals of getting the most value out of money spent on health care.

As health care systems move toward more value-based decision-making, there is a great need for generating new data, not just an analysis of data that already exists, former Merck & Co. Inc. executive Ian Spatz said, adding that the private sector will be playing a key role in its development.

“The search for value is the right one,” Spatz, former VP for global health policy for Merck, said in an interview. He is currently senior advisor in the national health...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Market Access

More from Pink Sheet

EMA Official Clarifies Benefits And Limitations Of Innovation Pathways

 
• By Eliza Slawther

A European Medicines Agency official provided an overview and update of the support the EMA offers developers of innovative products and discussed, among other things, its Innovation Task Force, Quality Innovation Group and a scientific advice pilot for clinical trials.

EU Emergency Response Authority Needs Bigger Budget To Address Health Threats, Says Industry

 
• By Eliza Slawther

The EU must renew the mandate of its Health Emergency Response Authority to support medicine stockpiles and enable agile manufacturing to combat antimicrobial resistance and chemical, biological, radiological and nuclear threats, says trade organization EUCOPE.